Exhibit 107
CALCULATION OF FILING FEE TABLE
Form S-8
(Form Type)
Celldex Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
|
Security |
Title of securities to be registered |
Fee Calculation Rule |
Amount to be registered(1) |
Proposed maximum offering price per share(2) |
Proposed |
Fee Rate | Amount of registration fee(2) |
| Equity | Common Stock, $0.001 par value per share | Rule 457(c) and Rule 457(h) | 3,200,000 | $35.015 | $112,048,000 | 0.00014760 | $16,538.28 |
| Total Offering Amounts | $112,048,000 | $16,538.28 | |||||
| Total Fee Offsets(3) | — | ||||||
| Net Fee Due | $16,538.28 | ||||||
| (1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the Company’s common stock that become issuable under the Company’s 2021 Omnibus Equity Incentive Plan (the “Plan”) in respect of the securities identified in the above table by reason of any stock dividend, stock split, recapitalization, or other similar transaction effected without the Company’s receipt of consideration that increases the number of the outstanding shares of the Company’s common stock. | |
| (2) | Pursuant to Rules 457(c) and (h) under the Securities Act, the proposed maximum offering price per share and the proposed maximum aggregate offering price are estimated for the purpose of calculating the amount of the registration fee and are based on the average of the high and low sales price of the Company’s common stock as reported on the NASDAQ Stock Market on June 11, 2024. | |
| (3) | The Registrant does not have any fee offsets. |